1.Treatment of tibial fractures through compression reduction and osteosynthesis with common plate
Sheng DING ; Guoquan SONG ; Chunqing WU ; Zhuo WANG ;
Chinese Journal of Orthopaedic Trauma 2004;0(11):-
Objective To evaluate clinical effects of the treatment of tibial fractures through compression reduction and osteosynthesis with common plate. Methods From March 2001 to September 2003, 48 cases of tibial fractures were treated through compression reduction and osteosynthesis with common plate. Results All the cases were followed up for 6 to 24 weeks (averaging 14 weeks). The healing time was 12 to 16 weeks (averaging 5 weeks). No delayed union, non union, infection, or ineffective internal fixation occurred. Conclusion Compression reduction and osteosynthesis with common plate to treat tibial fractures is a kind of biomechanical fixation that facilitates fracture healing.
2.Application of quality control circle activities in the design of protective constraint quilt
Yan YANG ; Meihua ZHANG ; Juanying LU ; Xiaomin FENG ; Xianying ZHANG ; Chunqing SHENG
Chinese Journal of Modern Nursing 2016;22(5):717-719,720
Objective Protective constraint quilt is designed by applying quality control circle activities to improve the property of warmth for visible dysphoria patients and to reduce the rate of unplanned extubation. Methods Quality control circle group finally designed a kind of protective constraint quilt under the theme of“improve the warmth retention property for visible dysphoria patients, reduce the rate of unplanned extubation”. The protective constraint quilt was used in 40 patients, whose treatment effects were compared with patients controlled by limb restraint strap, chest belt and restraint gloves before the implementation of quality control circle activities in terms of the damage rate of skin integrity, the extubation rate, the property of warmth and satisfaction of patients′ families. Results The protective constraint quilt was adjusted for 6 times by quality control circle group. After improvement, the satisfaction degree of patients′ families improved from 75. 0% to 95. 0%, the property of warmth was better and the extubation rate was lower than those of protective constraint quilt before improvement along with significant differences (P<0. 05). There was no significant difference in extremities blood circulation and skin integrity (P > 0. 05). Conclusions This activity improves group members′scientific thinking and innovation ability. The protective constraint quilt designed by quality control circle is effective to be applied to visible dysphoria patients. Satisfaction of patients′ families with this way of constraint is high. In conclusion, protective constraint quilt is worthy of popularizing and applying.
3.Molecular genetic analysis and identification of novel alleles of ABO subtypes
Jun SU ; Xigang WANG ; Hongxia YANG ; Lingling CHE ; Tiantian REN ; Chunqing YANG ; Ling ZHAO ; Sheng WANG
Chinese Journal of Blood Transfusion 2024;37(2):145-150
【Objective】 To study the molecular mechanism of 95 samples of serological ABO subtypes. 【Methods】 A total of 95 samples with discrepancy between forward and reverse blood grouping were subjected to serological confirmation, and genotyped by polymerase chain reaction with sequence-specific primers (PCR-SSP). For those subtype alleles could not be detected by PCR-SSP, ABO gene exon 1-7 sequencing and gene single strand sequencing were performed successively to determine the mutation site and the gene location. 【Results】 A total of 34 ABO alleles were detected in 95 samples. Five common ABO alleles (ABO*A1.01, ABO*A1.02, ABO*B.01, ABO*O.01.01 and ABO*O.01.02) and 29 rare ABO alleles were identified, including 16 named alleles by ISBT (ABO*A2.01, ABO*A2.05, ABO*A2.13, ABO*A3.07, ABO*AW.37, ABO*AEL.05, ABO*B3.01, ABO*B3.05, ABO*BW.03, ABO*BW.07, ABO*BW.27, ABO*BEL.03, ABO*cisAB.01, ABO*cisAB.05, ABO*BA.02, ABO*BA.04) and 5 named alleles by dbRBC(A223, B309, Bw37, Bel09, Bw40)and eight unnamed alleles [ABO*B.01+ 978C>A, ABO*A1.02+ 248A>T, ABO*B.01+ 125dupT, ABO*B.01+ (98+ 1G>A), ABO*A1.02/ABO*B.01+ 1A>G, ABO*A1.02/ABO*O.01.01+ 28G>T, ABO*A1.02/ABO*B.01+ 538C>T, ABO*A1.02/ABO*O.01.01+ 797insT] .The last four samples could not be verified by single strand because of insufficient samples. In 95 samples, 76 samples (21 named alleles of ISBT and dbRBC) were identified by PCR-SSP, and the remaining 19 samples were identified by exon 1-7 sequencing of ABO gene, of which 8 were identified as unnamed alleles, and the remaining 11 samples were not identified as subtype alleles. 【Conclusion】 The molecular genetic mechanism of 95 serological ABO subtypes was revealed, and 8 rare novel alleles were identified. The detection of ambiguous blood groups is influenced by factors such as patient pathology and physiology, therefore the combination of serological testing and genetic testing is suggested for the identification of ABO subtype.